Tuberculosis News and Research

Latest Tuberculosis News and Research

Zimbabwe set to attain 'universal' ARV coverage

"Zimbabwe is set to attain 'universal' coverage for AIDS treatment thanks in part to an $84 million disbursement on Tuesday by the United Nations-backed Global Fund to Fight AIDS, Tuberculosis and Malaria," the U.N. News Centre reports.

4 Oct 2012

Blog assesses key elements of Global Fund's new funding model

In an article on the International HIV/AIDS Alliance's webpage, the organization compares a new funding model adopted by the Global Fund to Fight AIDS, Tuberculosis and Malaria to its own "key principles" and "outline[s] how civil society is involved in refining the process of how money will be allocated."

4 Oct 2012

Advocacy group's aid transparency index shows more openness but room for improvement

"As a major international deadline on foreign assistance transparency draws closer, a new index shows that while donors are becoming more open with their data, still less than half of foreign aid information is openly available," Inter Press Service reports.

4 Oct 2012

IRIN examines allegations of Global Fund grant misuse in Uganda

IRIN reports on allegations that a grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria to Uganda was misused. "Evidence of the mismanagement of a $51 million malaria grant to Uganda from the Global Fund resulted in the July arrest of three Ministry of Health employees and prompted a police investigation into the matter," the news service writes.

3 Oct 2012

FDA approves Abbott’s HUMIRA to treat ulcerative colitis

Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved HUMIRA (adalimumab) for inducing and sustaining clinical remission in adult patients with moderately to severely active ulcerative colitis (UC) when certain other medicines have not worked well enough.

29 Sep 2012

EC approves Janssen’s DACOGEN for treatment of de novo acute myeloid leukaemia

Janssen-Cilag International NV announced today that the European Commission has approved the marketing authorisation for DACOGEN(decitabine) for the treatment of adult patients (age 65 years and above) with newly diagnosed de novo or secondary acute myeloid leukaemia (AML), according to the World Health Organisation (WHO) classification, who are not candidates for standard induction chemotherapy.

28 Sep 2012

Large donors dictating direction of global health research, financing, essay says

"When it comes to getting aid right, an all-too-familiar problem seems to be balancing the priorities of rich governments with what communities actually want," AlertNet reports in an article examining an essay written by Oxford University researcher Devi Sridhar and published in PLOS Medicine.

28 Sep 2012

African leaders renew commitment to providing HIV treatment, prevention services

"African leaders meeting on the sidelines of the 67th session of the United Nations General Assembly called Wednesday for innovative solutions to accelerate the response to AIDS, tuberculosis and malaria and to advance health for people on the continent," the U.N. News Centre reports.

28 Sep 2012

Key bacterial protein structures reveal one of the biochemical secrets behind multi-drug tolerance

The structures of key bacterial proteins have revealed one of the biochemical secrets that enables bacteria to outwit antibiotics.

27 Sep 2012

IRIN examines reaction to Global Fund's new funding approach

"The Global Fund to Fight AIDS, Tuberculosis and Malaria has released initial details on its new funding model, ... but as the fund works to finalize the model before next year, civil society is criticizing the process for being untransparent and rushed," IRIN reports in an article examining the draft model and reaction to it.

27 Sep 2012

Coca Cola, Global Fund announce expansion of project to deliver medicines in rural areas

The Coca-Cola Company and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the expansion of a pilot project, called "Project Last Mile," that uses Coca Cola's "'expansive global distribution system and core business expertise' to help deliver critical medicines to remote parts of the world, beginning in rural Africa," Pharma Times reports.

27 Sep 2012

Presidential candidates should address HIV epidemic more directly

Following the XIX International AIDS Conference (AIDS 2012) in July, "delegates left Washington with a clear focus on achieving an AIDS-free generation," Chip Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, writes in the Huffington Post's "The Big Push" blog.

26 Sep 2012

Forbes features interview with president of Friends of Global Fight

Forbes features an interview with Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, in which she "discusse[s] her motivations for pursuing a career in international affairs and social change, her experience as a senior program officer at the [Bill & Melinda Gates Foundation], what lessons she learned during her time at Gates that are most applicable in her new executive role at Friends of the Global Fight, the current landscape of challenges and solutions, and the role of technology in accelerating progress."

26 Sep 2012

Sufficient resources needed to maintain progress against AIDS, TB, malaria

"This week, heads of state, celebrities and CEOs will attend U.N. Secretary General Ban Ki-moon's 'Every Woman, Every Child' dinner in New York," an event that "will highlight the amazing contribution of the Global Fund to Fight AIDS, Tuberculosis and Malaria to the health of women and children in developing countries," Lucy Chesire, executive director and secretary to the board of TB ACTION Group, writes in the Huffington Post's "The Big Push" blog.

26 Sep 2012

Chinese innovations, resources could help create new global health products

In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Christine Rousseau, a program officer at the foundation, describes the importance of diagnostics in HIV/AIDS and tuberculosis (TB) care and treatment and writes, This brings me to the tremendous role that China's entrepreneurs can play as partners in global health.

26 Sep 2012

'Big Push' needed to ensure political will necessary to maintain progress against AIDS, TB, malaria

"What will the day be like when we finally defeat AIDS, tuberculosis and malaria?" Arianna Huffington, president and editor-in-chief of the Huffington Post Media Group, asks in the Huffington Post's "The Big Push" blog.

26 Sep 2012

IVAC at Johns Hopkins announces grant recipients of World Pneumonia Day Advocacy Program

The International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health (JHSPH) announced today recipients of the 2012 Small Grants for World Pneumonia Day Advocacy Program.

25 Sep 2012

U.S. foreign aid critical to achieving health goals, improving lives, strengthening international relationships

"Day after day, American foreign aid is dramatically improving millions of lives and consequently, impressions of America," former New Jersey Governor Thomas Kean and Ray Chambers, chair of the MDG Health Alliance and the U.N. Secretary-General's Special Envoy for Malaria, write in the Huffington Post's "Global Motherhood" blog.

21 Sep 2012

Sanofi, TB Alliance form research collaboration to search for new treatment compounds

French drug maker Sanofi on Thursday announced a new three-year research collaboration agreement with the TB Alliance "to accelerate the discovery and development of novel compounds against tuberculosis," RTTNews reports.

21 Sep 2012

U.N. report on MDGs shows declining aid; SG Ban urges increased global partnership

U.N. Secretary-General Ban Ki-moon on Thursday "urged a stronger global partnership to advance progress on the development targets world leaders have pledged to achieve by 2015, as a new United Nations report finds that significant gains risk slowing due to declining aid," the U.N. News Centre reports.

21 Sep 2012

Tuberculosis News and Research

Latest Tuberculosis News and Research

Zimbabwe set to attain 'universal' ARV coverage

Blog assesses key elements of Global Fund's new funding model

Advocacy group's aid transparency index shows more openness but room for improvement

IRIN examines allegations of Global Fund grant misuse in Uganda

FDA approves Abbott’s HUMIRA to treat ulcerative colitis

EC approves Janssen’s DACOGEN for treatment of de novo acute myeloid leukaemia

Large donors dictating direction of global health research, financing, essay says

African leaders renew commitment to providing HIV treatment, prevention services

Key bacterial protein structures reveal one of the biochemical secrets behind multi-drug tolerance

IRIN examines reaction to Global Fund's new funding approach

Coca Cola, Global Fund announce expansion of project to deliver medicines in rural areas

Presidential candidates should address HIV epidemic more directly

Forbes features interview with president of Friends of Global Fight

Sufficient resources needed to maintain progress against AIDS, TB, malaria

Chinese innovations, resources could help create new global health products

'Big Push' needed to ensure political will necessary to maintain progress against AIDS, TB, malaria

IVAC at Johns Hopkins announces grant recipients of World Pneumonia Day Advocacy Program

U.S. foreign aid critical to achieving health goals, improving lives, strengthening international relationships

Sanofi, TB Alliance form research collaboration to search for new treatment compounds

U.N. report on MDGs shows declining aid; SG Ban urges increased global partnership

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in